Hyderabad, India, July 22, 2008
GVK Biosciences (GVK BIO), Asia’s leading Contract Research Organization, today announced the appointment of Prof. Tarun Khanna to its Board of Directors.
Dr.Tarun Khanna is the Jorge Paulo Lemann Professor at the Harvard Business School, where he has been a member of the Strategy group since 1993. He holds a BS degree from Princeton University and a Ph.D. from Harvard University. Dr.Khanna heads the Strategy course in the Harvard MBA program and the Strategy, Leadership & Governance Executive Education program. He also lectures and consults with companies and governments worldwide. Dr.Khanna has contributed articles to Harvard Business Review and Foreign Policy and has served as an expert for major news organizations such as Wall Street Journal, The Economist, the Far Eastern Economic Review, CNN, and CNBC.
“We are very excited that Tarun has joined our Board of Directors. Tarun’s vast experience in global strategy and understanding of the emerging markets will facilitate GVK BIO to grow to the next level “, said Mr.D.S.Brar, Chairman, GVK Biosciences.
Serving on the Advisory Boards of several multinational and emerging market companies in the financial services, automotive, life sciences and agribusiness sectors, Dr. Khanna has experience in a wide variety of industries. He was nominated a Young Global Leader by the World Economic Forum in 2007.
Dr.Tarun Khanna said that, “I am pleased to join the GVK Biosciences Board of Directors at this exciting time of the Company and Industry and I look forward to this association.”
About GVK BIO
GVK Biosciences (www.gvkbio.com), Asia’s leading Contract Research Organization, delivers integrated research services to big Pharma and Biotech companies globally. The company accelerates the Drug Discovery and Development process of its customers through science and innovation. Currently the company has more than 1,300 employees spread across facilities in Hyderabad, Mumbai and Gurgaon.
For any further information, please contact: